Richard C. Shelton, MD

Original Research

MDDScore: Confirmation of a Blood Test to Aid in the Diagnosis of Major Depressive Disorder

February 25, 2015

John A. Bilello, Linda M. Thurmond, Katie M. Smith, et al

Original Research

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

April 15, 2014

George I. Papakostas, Richard C. Shelton, John M. Zajecka, et al

Article

Assessing Effects of l-Methylfolate in Depression Management: Results of a Real-World Patient Experience Trial

August 29, 2013

Richard C. Shelton, J. Sloan Manning, Lori W. Barrentine, et al

Original Research

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

December 15, 2012

George I. Papakostas, Ottavio V. Vitolo, Waguih W. IsHak, et al

Educational Activity

Using Algorithms and Computerized Decision Support Systems to Treat Major Depression

December 15, 2011

Richard C. Shelton, Madhukar H. Trivedi

Educational Activity

Moderators of Antidepressant Response in Major Depression

October 18, 2011

Richard C. Shelton, Madhukar H. Trivedi

Educational Activity

Performance Improvement CME: Algorithms and EMRs in Depression

September 15, 2011

Richard C. Shelton, Madhukar H. Trivedi

Educational Activity

Evidence for the Use of <span style="font-variant:small-caps;">l</span>-Methylfolate Combined With Antidepressants in MDD

August 15, 2011

Maurizio Fava, Richard C. Shelton, John M. Zajecka

Educational Activity

Using Moderator-Based Algorithms and Electronic Medical Records to Achieve Optimal Outcomes in Depression

July 15, 2011

Richard C. Shelton, Madhukar H. Trivedi

Educational Activity

Challenges and Algorithm-Guided Treatment in Major Depressive Disorder

April 15, 2011

Richard C. Shelton, Madhukar H. Trivedi

Educational Activity

Crisis of Confidence: Antidepressant Risk Versus Benefit

March 15, 2011

Andrew A. Nierenberg, Andrew C. Leon, Lawrence H. Price, et al

Original Research

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

February 22, 2011

James G. Barbee, Thomas R. Thompson, Nowal J. Jamhour, et al

MDDScore: Confirmation of a Blood Test to Aid in the Diagnosis of Major Depressive Disorder

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

Assessing Effects of l-Methylfolate in Depression Management: Results of a Real-World Patient Experience Trial

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

Using Algorithms and Computerized Decision Support Systems to Treat Major Depression

Moderators of Antidepressant Response in Major Depression

Performance Improvement CME: Algorithms and EMRs in Depression

Evidence for the Use of <span style="font-variant:small-caps;">l</span>-Methylfolate Combined With Antidepressants in MDD

Using Moderator-Based Algorithms and Electronic Medical Records to Achieve Optimal Outcomes in Depression

Challenges and Algorithm-Guided Treatment in Major Depressive Disorder

Crisis of Confidence: Antidepressant Risk Versus Benefit

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

ELSEWHERE:

FOLLOW US:

Richard C. Shelton, MD

MDDScore: Confirmation of a Blood Test to Aid in the Diagnosis of Major Depressive Disorder

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

Assessing Effects of l-Methylfolate in Depression Management: Results of a Real-World Patient Experience Trial

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

Using Algorithms and Computerized Decision Support Systems to Treat Major Depression

Moderators of Antidepressant Response in Major Depression

Performance Improvement CME: Algorithms and EMRs in Depression

Evidence for the Use of <span style="font-variant:small-caps;">l</span>-Methylfolate Combined With Antidepressants in MDD

Using Moderator-Based Algorithms and Electronic Medical Records to Achieve Optimal Outcomes in Depression

Challenges and Algorithm-Guided Treatment in Major Depressive Disorder

Crisis of Confidence: Antidepressant Risk Versus Benefit

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles